News
EPRX Eupraxia Pharmaceuticals, In.. (TOR)
-
- Last: 4.00
- Change: 0.00 (0.00%)
| Eupraxia Pharmaceuticals to Present Initial Results from Ongoing Phase 1b Study of EP-104GI for the Treatment of Eosinophilic Esophagitis at Upcoming Digestive Disease Week Annual Meeting 2024 — Comtex07:01 AM ET 05/14/2024 VICTORIA, BC, May 14, 2024 /PRNewswire via COMTEX News Network/ -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company... |
| Eupraxia Pharmaceuticals to Present Initial Results from Ongoing Phase 1b Study of EP-104GI for the Treatment of Eosinophilic Esophagitis at Upcoming Digestive Disease Week Annual Meeting 2024 — Comtex07:00 AM ET 05/14/2024 Canada NewsWire |
| Eupraxia Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update — Comtex05:04 PM ET 05/08/2024 VICTORIA, BC, May 8, 2024 /PRNewswire via COMTEX News Network/ -- -- Eupraxia common shares now listed on the Nasdaq Capital Market ("Nasdaq") under the symbol "EPRX" |
| Eupraxia Pharmaceuticals Announces Gastrointestinal Clinical Advisory Board — Comtex07:01 AM ET 05/02/2024 VICTORIA, BC, May 2, 2024 /PRNewswire via COMTEX News Network/ -- Advisory Board to Provide Guidance for Company's Eosinophilic Esophagitis Clinical Program-- |
| Eupraxia Pharmaceuticals Announces Gastrointestinal Clinical Advisory Board — Comtex07:01 AM ET 05/02/2024 Canada NewsWire |
| Eupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024 — Comtex07:00 AM ET 04/11/2024 VICTORIA, BC, April 11, 2024 /PRNewswire via COMTEX News Network/ -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company... |
| Eupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024 — Comtex07:00 AM ET 04/11/2024 Canada NewsWire |
| Eupraxia Pharmaceuticals To Present at Bloom Burton & Co. Healthcare Investor Conference — Comtex07:01 AM ET 04/08/2024 VICTORIA, BC, April 8, 2024 /PRNewswire via COMTEX News Network/ -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX); (NASDAQ: EPRX), a clinical-stage biotechnology company... |
| Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today — Comtex07:00 AM ET 04/05/2024 VICTORIA, BC, April 5, 2024 /PRNewswire via COMTEX News Network/ -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX); (NASDAQ: EPRX), a clinical-stage biotechnology company... |
| Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today — Comtex07:00 AM ET 04/05/2024 Canada NewsWire |
Quotes delayed at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement.